← Evidence map

ReviewCureus2024

The Evolving Role of Monomethyl Fumarate Treatment as Pharmacotherapy for Relapsing-Remitting Multiple Sclerosis.

Alan D Kaye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38711693